Homocysteine and hemostasis: Pathogenetic mechanisms predisposing to thrombosis

Journal of Nutrition

Volumn 126, Issue 4 SUPPL., 1996, Pages

  Harpel, Peter C ^a,b   Zhang, Xiaoxia ^a   Borth, Wolfgang ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Box 1079 ^*  (United States)

Author keywords

anticoagulant; hemostasis; hyperhomocysteinemia; lipoprotein(a); thrombosis

Indexed keywords

ANTICOAGULANT AGENT; HOMOCYSTEINE; LIPOPROTEIN A; APYRASE; HEPARAN SULFATE; PROTEIN C; THROMBOPLASTIN; TISSUE PLASMINOGEN ACTIVATOR;

ATHEROSCLEROSIS; CELL MEMBRANE FLUIDITY; CELL PROLIFERATION; CONFERENCE PAPER; ENZYME ACTIVITY; GENETIC PREDISPOSITION; HEMOSTASIS; HOMOCYSTINURIA; HUMAN; HUMAN CELL; PATHOGENESIS; SMOOTH MUSCLE FIBER; THROMBOSIS; VASCULAR ENDOTHELIUM; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; PHYSIOLOGY; REVIEW; VASCULAR SMOOTH MUSCLE;

ANIMALS; APYRASE; ENDOTHELIUM, VASCULAR; HEMOSTASIS; HEPARITIN SULFATE; HOMOCYSTEINE; HUMANS; MUSCLE, SMOOTH, VASCULAR; PROTEIN C; THROMBOPLASTIN; THROMBOSIS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0030119805     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/126.suppl_4.1285s     Document Type: Conference Paper

References (33)

1. Bevilacqua, M. P., Pober, J. S., Majeau, G. R., Cotran, R. S. & Gimbrone, M. A. (1984) Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J. Exp. Med. 160: 618-623.
2. Broekman, M. J., Hajjar, K. A., Marcus, A. J., Lev, E., Islam, N., Safler, L. B. & Fliessbach, J. (1994) Homocysteine inhibits ecto-ADPase activity of human umbilical vein endothelial cells. Blood 84 (suppl 1): 77 (abs.).
3. Brox, J. H., Osterud, B., Bjklid, E. & Fenton, J. W. (1984) Production and availability of thromboplastin in endothelial cells: the effects of thrombin, endotoxin and platelets. Br. J. Haematol. 57: 239-246.
4. Dittman, W. A. & Majerus, P. W. (1990) Structure and function of thrombomodulin: a natural anticoagulant. Blood 75: 329-336.
5. Edgington, T. S., Mackman, N., Brand, K. & Ruf, W. (1991) The structural biology of expression and function of tissue factor. Thromb. Haemost. 66: 67-79.
6. Esmon, C. T. (1989) The roles of protein C and thrombomodulin in the regulation of blood coagulation. J. Biol. Chem. 264: 4743-4746.
7. Falcon, C. R., Cattaneo, M., Panzeri, D., Martinelli, I. & Mannucci, P. M. (1994) High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis. Arterioscler. Thromb. 14: 1080-1083.
8. Fryer, R. H., Wilson, B. D., Gubler, D. B., Fitzgerald, L A. & Rodgers, G. M. (1993) Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. Arterioscler. Thromb. 13: 1327-1333.
9. Gerrits, W. B. J., den Heyer, M., Blom, H. J., Rosendaal, F. R. & Bos, G. M. J. (1994) Hyperhomocysteinemia and recurrent venous thrombosis. Blood 84 (suppl 1): 81 (abs.).
10. Gladson, C. L., Scharrer, I. & Hach, V. (1988) The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis. Thromb. Haemost. 59: 18-22.
11. Hajjar, K. A. (1991a) Assembly of the fibrinolytic system on endothelial cells. In: Thrombolysis: Basic Contributions and Clinical Progress (Haber, E. & Braunwald, E., eds.), pp. 27-32. Mosby-Year Book, St. Louis, MO.
12. Hajjar, K. A. (1991b) The endothelial cell tissue plasminogen activator receptor. J. Biol. Chem. 266: 21962-21970.
13. Hajjar, K. A. (1993) Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor. J. Clin. Invest. 91: 2873-2879.
14. Hajjar, K. A., Hamel, N. M., Harpel, P. C. & Nachman, R. L. (1987) Binding of tissue plasminogen activator to cultured human endothelial cells. J. Clin. Invest. 80: 1712-1719.
15. Hajjar, K. A., Harpel, P. C., Jaffe, E. A. & Nachman, R. L. (1986) Binding of plasminogen to cultured human endothelial cells. J. Biol. Chem. 261: 11656-11662.
16. Harpel, P. C., Chang, V. T. & Borth, W. (1992) Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis and sulfhydryl compound metabolism. Proc. Natl. Acad. Sci. U.S.A. 89: 10193-10197.
17. Harpel, P. C., Gordon, B. R. & Parker, T. S. (1989) Plasmin catalyzes binding of lipoprotein(a) to immobilized fibrinogen and fibrin. Proc. Natl. Acad. Sci. U.S.A. 86: 3847-3851.
18. Hayashi, T., Honda, G. & Suzuki, K. (1992) An atherogenic stimulus homocysteine inhibits cofactor activity of thrombomodulin and enhances thrombomodulin expression in human umbilical vein endothelial cells. Blood 79: 2930-2936.
19. Lentz, S. R. & Sadler, J. E. (1991) Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. J. Clin. Invest. 88: 1906-1914.
20. Lentz, S. R. & Sadler, J. E. (1993) Homocysteine inhibits von Willebrand factor processing and secretion by preventing transport from the endoplasmic reticulum. Blood 81: 683-689.
21. McLean, J. W., Tomlinson, J. E., Kuang, W. J., Eaton, D. L., Chen, E. Y., Fless, G. M., Scanu, A. M. & Lawn, R. M. (1987) cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 330: 132-137.
22. Moore, K. S., Andreoli, S. P., Esmon, N. L., Esmon, C. T. & Bang, N. U. (1987) Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J. Clin. Invest. 79: 124-130.
23. Mudd, S. H., Levy, H. L. & Skovby, F. (1989) Disorders of transsulfuration. In: The Metabolic Basis of Inherited Disease (Scriver, C. R., Beaudet, A. L., Sly, W. S. & Valle, D., eds.), pp. 693-734. McGraw-Hill, New York, NY.
24. Mulder, A. B., Hegge-Paping, S. M., Magielse, C. P. E., Blom, N. R., Smit, J. W. & van der Meer, J. (1994) Tumor necrosis factor α-induced endothelial tissue factor is located on the cell surface rather than in the subendothelial matrix. Blood 84: 1559-1566.
25. Nemerson, Y. (1992) The tissue factor pathway of blood coagulation. Semin. Hematol. 29: 170-176.
26. Nishinaga, M., Ozawa, T. & Shimada, K. (1993) Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells. J. Clin. Invest. 92: 1381-1386.
27. Rodgers, G. M. & Conn, M. T. (1990) Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells. Blood 75: 895-901.
28. Rodgers, G. M. & Kane, W. H. (1986) Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator. J. Clin. Invest. 77: 1909-1916.
29. Rosenberg, R. D. & Rosenberg, J. S. (1984) Natural anticoagulant mechanisms. J. Clin. Invest. 74: 1-6.
30. Rosendaal, F. R., Koster, T., Vandenbroucke, J. P. & Reitsma, P. H. (1995) High risk of thrombosis in patients homozygous for Factor V Leiden (activated Protein C resistance). Blood 85: 1504-1508.
31. Starkebaum, G. & Harlan, J. M. (1986) Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J. Clin. Invest. 77: 1370-1376.
32. Svensson, P. J. & Dahlback, B. (1994) Resistance to activated protein C as a basis for venous thrombosis. N. Engl. J. Med. 330: 517-522.
33. Tsai, J-C., Perrella, M. A., Yoshizumi, M., Hsieh, C-M., Haber, E., Scaelgel, R. & Lee, M-E. (1994) Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc. Natl. Acad. Sci. U.S.A. 91: 6369-6373.